MariMed (OTC:MRMD – Get Free Report) and GLG Life Tech (OTCMKTS:GLGLF – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.
Profitability
This table compares MariMed and GLG Life Tech’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| MariMed | -8.95% | 1.58% | 0.53% |
| GLG Life Tech | 498.04% | N/A | -107.46% |
Analyst Ratings
This is a breakdown of current recommendations for MariMed and GLG Life Tech, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| MariMed | 0 | 0 | 0 | 1 | 4.00 |
| GLG Life Tech | 0 | 0 | 0 | 0 | 0.00 |
Institutional and Insider Ownership
0.2% of MariMed shares are held by institutional investors. 19.0% of MariMed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares MariMed and GLG Life Tech”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| MariMed | $148.60 million | 0.18 | -$16.03 million | ($0.03) | -2.27 |
| GLG Life Tech | $10.62 million | 0.00 | $48.29 million | $1.32 | N/A |
GLG Life Tech has lower revenue, but higher earnings than MariMed. MariMed is trading at a lower price-to-earnings ratio than GLG Life Tech, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
MariMed has a beta of 2.99, indicating that its stock price is 199% more volatile than the S&P 500. Comparatively, GLG Life Tech has a beta of 1.84, indicating that its stock price is 84% more volatile than the S&P 500.
Summary
MariMed beats GLG Life Tech on 8 of the 12 factors compared between the two stocks.
About MariMed
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
About GLG Life Tech
GLG Life Tech Corporation researches for, develops, grows, refines, and produces natural sweeteners extracted from the stevia plant and monk fruit in Canada and internationally. It also offers P-Pro Plus, a pea protein product; REB M GOLD, a bioconverted Rebaudioside M and Rebaudioside D. sweetener; and natural ingredients. It serves in the food and beverage industry. The company was formerly known as GLG Life Tech Limited and changed its name to GLG Life Tech Corporation in March 2007. GLG Life Tech Corporation was incorporated in 1998 and is headquartered in Richmond, Canada.
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
